Prostate cancer is the most common malignancy in men and ductal adenocarcinoma is a pathologic subtype with specific histological and clinical features. Seventy-six year-old male patient with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) admitted to our hospital with lower urinary tract symptoms. The last prostate specific antigen (PSA) level was 26 ng/ml and serial transrectal ultrasound guided biopsies were administered and benign prostate hyperplasia and non-specific prostatitis were the results of pathology reports. Due to the persistence of the symptoms transurethral resection of the prostate was performed. In the pathologic evaluation of the material adenocarcinoma focuses without stroma has been observed between t...
Abstract Introduction Ductal adenocarcinoma is a rare variety of the common acinar adenocarcinoma. I...
Background: To evaluate the clinical characteristics, contemporary treatment options, and outcome of...
Prostatic adenocarcinoma is the most common cancer in men, and is the 3rd leading cause of death in ...
Prostate cancer is the most common malignancy in men and ductal adenocarcinoma is a pathologic subty...
BACKGROUND: We describe a patient who underwent transurethral resection of the prostate for urinary ...
We report a case of seventy-four year-old male with advanced urinary tract obstruction symptoms and ...
Ductal adenocarcinoma of the prostate (DAC) is recognised as a subtype of prostatic adenocarcinoma, ...
Prostate cancer is a disease with a variable clinical course. The possible impact on oncological out...
We report a rare case of a primary malignant lymphoma of the prostate, which presented as urinary re...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Malignant lymphomas of the prostate are very rare tumours and are generally not considered in the cl...
Ductal adenocarcinoma is a variant of prostatic adenocarcinoma, originating from the epithelial lini...
Involvement of the prostate gland by non-Hodgkin lymphoma (NHL) is very rare. Most frequent histolog...
Abstract. We introduced a 61-year-old male with ductal adenocarcinoma of the prostate who underwent ...
Study Type - Prognosis (case series) Level of Evidence 4 Objective To report the clinicopathological...
Abstract Introduction Ductal adenocarcinoma is a rare variety of the common acinar adenocarcinoma. I...
Background: To evaluate the clinical characteristics, contemporary treatment options, and outcome of...
Prostatic adenocarcinoma is the most common cancer in men, and is the 3rd leading cause of death in ...
Prostate cancer is the most common malignancy in men and ductal adenocarcinoma is a pathologic subty...
BACKGROUND: We describe a patient who underwent transurethral resection of the prostate for urinary ...
We report a case of seventy-four year-old male with advanced urinary tract obstruction symptoms and ...
Ductal adenocarcinoma of the prostate (DAC) is recognised as a subtype of prostatic adenocarcinoma, ...
Prostate cancer is a disease with a variable clinical course. The possible impact on oncological out...
We report a rare case of a primary malignant lymphoma of the prostate, which presented as urinary re...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Malignant lymphomas of the prostate are very rare tumours and are generally not considered in the cl...
Ductal adenocarcinoma is a variant of prostatic adenocarcinoma, originating from the epithelial lini...
Involvement of the prostate gland by non-Hodgkin lymphoma (NHL) is very rare. Most frequent histolog...
Abstract. We introduced a 61-year-old male with ductal adenocarcinoma of the prostate who underwent ...
Study Type - Prognosis (case series) Level of Evidence 4 Objective To report the clinicopathological...
Abstract Introduction Ductal adenocarcinoma is a rare variety of the common acinar adenocarcinoma. I...
Background: To evaluate the clinical characteristics, contemporary treatment options, and outcome of...
Prostatic adenocarcinoma is the most common cancer in men, and is the 3rd leading cause of death in ...